Cargando…
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
BACKGROUND: Novel buprenorphine dosing strategies have emerged with an aim to transition patients from opioid agonists to buprenorphine without prerequisite opioid withdrawal. We applied a configurational approach to a subset of data from our earlier systematic review to answer the following questio...
Autores principales: | K. K., Adams, E. J., Miech, D. M., Sobieraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531395/ https://www.ncbi.nlm.nih.gov/pubmed/36195895 http://dx.doi.org/10.1186/s13722-022-00336-z |
Ejemplares similares
-
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review
por: Adams, K. K., et al.
Publicado: (2021) -
Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016) -
Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022) -
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021) -
Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018)